Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Oragenics Inc. (OGEN)

The daily price chart for Oragenics, Inc. (OGEN) reflects an EV/EBITDA ratio of 0.00. Oragenics, Inc. (OGEN) promotes anti-infection agents and nasal vaccines, partnering with biotech centers to accelerate trials and attract buyers. The business remains independent of market cycles, relying solely on the success of its tests. Currently, the company is deploying capital toward research and development, relying entirely on external investments.

Oragenics Inc. - Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan OGEN (periode 23.11.2025 - 12.11.2026)

Ringkesan rincian data analitis Oragenics Inc. (OGEN)

- rega saiki lan proyeksi nilai saham:

Rega saham Oragenics|OGEN - Target median analis

- rincian kapitalisasi pasar:

Nilai pasar Oragenics, Inc.|OGEN - Nilai Bisnis

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Oragenics|OGEN - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku oragenics.com|OGEN - Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal Oragenics, Inc.|OGEN - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Oragenics, Inc.|OGEN - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Oragenics, Inc.|OGEN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Oragenics|Likuiditas cepet oragenics.com

- rincian asil keuangan lan kelipatan valuasi:

OGEN - Bathi perusahaan|Bathi sing dikarepake Oragenics, Inc.|OGEN - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Oragenics|OGEN - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Oragenics, Inc.|OGEN - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Oragenics|OGEN - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan oragenics.com|OGEN - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Oragenics, Inc.

Analisis umum perusahaan:Oragenics OGEN

Oragenics, Inc. (OGEN) development of breakthrough intranasal therapies requires significant capital expenditures and debt load management. The EV/EBITDA metric compares the total enterprise value, including debt, with operating profit before interest, taxes, depreciation, and amortization, revealing the actual value of the assets. Analyzing the EV/EBITDA ratio of Oragenics, Inc. (OGEN) across a financial timeline allows investors to avoid overpaying for biotechnological potential by promptly identifying points of market capitulation.

Analisis perusahaan pesaing

Pangali EV/EBITDA SMMT (Summit Therapeutics Inc)|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Moderna Therapeutics (MRNA)|PCVX - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|TARS (tarsusrx.com) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|CRMD: Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan MCRB (Seres Therapeutics Inc.)|SPRO (Spero) - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Scynexis SCYX|Pangali EV/EBITDA ANTX|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan polypid.com PYPD|LakeShore Biopharma - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan ITRM (Iterum Therapeutics PLC)|BiomX Ltd - Pangali EV/EBITDA|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Soligenix, Inc. SNGX|60degreespharma.com (SXTP) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan opgen.com (OPGN)